Hepatotoxicity by Dietary Supplements: A tabular Listing and Clinical Characteristics

International Journal of Molecular Sciences

Volumn 17, Issue 4, 2016, Pages

  García Cortés, Miren ^a,b   Robles Díaz, Mercedes ^a,b   Ortega Alonso, Aida ^a   Medina Caliz, Inmaculada ^a   Andrade, Raul J ^a,b  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Anabolic steroids; Dietary supplements; Green tea; Hepatotoxicity; Herbalife products; Hydroxycut; Liver injury; Oxyelite Pro; Usnic acid; Vitamin A

Indexed keywords

4 METHYL 2 HEXYLAMINE; ANABOLIC AGENT; EPHEDRA SINICA EXTRACT; GARCINIA CAMBOGIA EXTRACT; GREEN TEA EXTRACT; LINOLEIC ACID; RETINOL; UNCOUPLING PROTEIN 1; USNIC ACID; PLANT MEDICINAL PRODUCT; TESTOSTERONE DERIVATIVE;

ACUTE LIVER FAILURE; BODY BUILDING; DIET SUPPLEMENTATION; EPHEDRA; HOSPITALIZATION; HUMAN; INSULIN SENSITIVITY; LIVER INJURY; LIVER TOXICITY; LIVER TRANSPLANTATION; PHENOTYPE; REVIEW; WEIGHT REDUCTION; ANALYSIS; CHEMICAL AND DRUG INDUCED LIVER INJURY; CHEMISTRY; CLINICAL TRIAL (TOPIC); DIETARY SUPPLEMENT; FEMALE; MALE; MEDICINAL PLANT; TOXICITY;

CHEMICAL AND DRUG INDUCED LIVER INJURY; CLINICAL TRIALS AS TOPIC; DIETARY SUPPLEMENTS; FEMALE; HUMANS; MALE; PLANT PREPARATIONS; PLANTS, MEDICINAL; TESTOSTERONE CONGENERS;

EID: 84963526763     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms17040537     Document Type: Review

References (159)

1. Serafini, M.; Stanzione, A.; Foddai, S.; Anton, R.; Delmulle, L. The European role on traditional herbalmedicinal products and traditional plant food supplements. J. Clin. Gastroenterol. 2012, 46, S93–S94. [CrossRef][PubMed]
2. European Medicines Agency. Committee on Herbal Medicinal Products (HMPC). Available online: http://www.ema.europa.eu/ema/index.jsp?curl=pages/about_us/general/general_con-tent_000264.jsp (accessed on 13 January 2014).
3. Commission on Dietary Supplement Labels. Chapter I Dietary Supplement Health And Education Act of 1994. Available online: http://www.health.gov/dietsupp/ch1.htm (accessed on 13 January 2014).
4. Radimer, K.; Bindewald, B.; Hughes, J.; Ervin, B.; Swanson, C.; Picciano, M.F. Dietary supplement use by US adults: Data from the National Health and Nutrition Examination Survey: 1999–2000. Am. J. Epidemiol. 2004, 160, 339–349. [CrossRef][PubMed]
5. Bailey, R.L.; Gahche, J.J.; Lentino, C.V.; Dwyer, J.T.; Engel, J.S.; Thomas, P.R.; Betz, J.M.; Sempos, C.T.; Picciano, M.F. Dietary supplement use in the United States: 2003–2006. J. Nutr. 2011, 141, 261–266. [CrossRef][PubMed]
6. Garcia-Alvarez, A.; Egan, B.; de Klein, S.; Dima, L.; Maggi, F.M.; Isoniemi, M.; Ribas-Barba, L.; Raats, M.M.; Meissner, E.M.; Badea, M., et al. Usage of plant food supplements across six European countries: Findings from the PlantLIBRA consumer survey. PLoS ONE 2014, 9, e92265.
7. Andrade, R.J.; Lucena, M.I.; Fernández, M.C.; Pelaez, G.; Pachkoria, K.; García-Ruiz, E.; García-Muñoz, B.; González-Grande, R.; Pizarro, A.; Durán, J.A., et al. Drug-induced liver injury: An analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology 2005, 129, 512–521. [CrossRef][PubMed]
8. García-Cortés, M.; Borraz, Y.; Lucena, M.I.; Peláez, G.; Salmerón, J.; Diago, M.; Martínez-Sierra, M.C.; Navarro, J.M.; Planas, R.; Soria, M.J., et al. Liver injury induced by “natural remedies”: An analysis of cases submitted to the Spanish Liver Toxicity Registry. Rev. Esp. Enferm. Dig. 2008, 100, 688–695. [PubMed]
9. Bjornsson, E.S.; Bergmann, O.M.; Bjornsson, H.K.; Kvaran, R.B.; Olafsson, S. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology 2013, 144, 1419–1425. [CrossRef][PubMed]
10. Navarro, V.J.; Barnhart, H.; Bonkovsky, H.L.; Davern, T.; Fontana, R.J.; Grant, L.; Reddy, K.R.; Seeff, L.B.; Serrano, J.; Sherker, A.H., et al. Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network. Hepatology 2014, 60, 1399–1408. [CrossRef][PubMed]
11. Robles-Diaz, M.; Gonzalez-Jimenez, A.; Medina-Caliz, I.; Stephens, C.; García-Cortes, M.; García-Muñoz, B.; Ortega-Alonso, A.; Blanco-Reina, E.; Gonzalez-Grande, R.; Jimenez-Perez, M., et al. Distinct phenotype of hepatotoxicity associated with illicit use of anabolic androgenic steroids. Aliment. Pharmacol. Ther. 2015, 41, 116–125. [CrossRef][PubMed]
12. Suk, K.T.; Kim, D.J.; Kim, C.H.; Park, S.H.; Yoon, J.H.; Kim, Y.S.; Baik, G.H.; Kim, J.B.; Kweon, Y.O.; Kim, B.I., et al. A prospective nationwide study of drug-induced liver injury in Korea. Am. J. Gastroenterol. 2012, 107, 1380–1387. [CrossRef][PubMed]
13. Wai, C.T.; Tan, B.H.; Chan, C.L.; Sutedja, D.S.; Lee, Y.M.; Khor, C.; Lim, S.G. Drug-induced liver injury at an Asian center: A prospective study. Liver Int. 2007, 27, 465–474. [CrossRef][PubMed]
14. Zhou, Y.; Yang, L.; Liao, Z.; He, X.; Guo, H. Epidemiology of drug-induced liver injury in China: A systematic analysis of the Chinese literature including 21,789 patients. Eur. J. Gastroenterol. Hepatol. 2013, 25, 825–829. [CrossRef][PubMed]
15. Stickel, F.; Kessebohm, K.; Weimann, R.; Seitz, H.K. Review of liver injury associated with dietary supplements. Liver Int. 2011, 31, 595–605. [CrossRef][PubMed]
16. Stickel, F.; Shouval, D. Hepatotoxicity of herbal and dietary supplements: An update. Arch. Toxicol. 2015, 89, 851–865. [CrossRef][PubMed]
17. Seef, L.; Stickel, F.; Navarro, V.J. Hepatotoxicity of herbals and dietary supplements. In Drug Induced Liver Disease, 3rd ed.; Kaplowitz, N., DeLeve, L.D., Eds.; Elsevier: Amsterdam, Holland, 2013; pp. 631–658.
18. Danan, G.; Benichou, C. Causality assessment of adverse reactions to drugs—I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuries. J. Clin. Epidemiol. 1993, 46, 1323–1330. [CrossRef]
19. Navarro, V.; Barnhart, H.; Bonkovsky, H.; Reddy, K.R.; Seeff, L.; Serrano, J.; Talwalkar, J.A.; Vega, M.; Vuppalanchi, R. Diagnosing hepatotoxicity attributable to herbal & dietary supplements (HDS): Test-retest reliability of a novel causality assessment tool. J. Hepatol. 2012, 56, S536.
20. Smith, D.A.; Perry, P.J. The efficacy of ergogenic agents in athletic competition Part I: Androgenic-anabolic steroids. Ann. Pharmacother. 1992, 26, 520–528. [PubMed]
21. Ishak, K.G. Hepatic lesions caused by anabolic and contraceptive steroids. Semin. Liver Dis. 1981, 1, 116–128. [CrossRef][PubMed]
22. Singh, V.; Rudraraju, M.; Carey, E.J.; Byrne, T.J.; Vargas, H.E.; Williams, J.E.; Balan, V.; Douglas, D.D.; Rakela, J. Severe hepatotoxicity caused by a methasteron-containing performance-enhancing supplement. J. Clin. Gastroenterol. 2009, 43, 287.
23. Timcheh-Hariri, A.; Balali-Mood, M.; Aryan, E.; Sadeghi, M.; Riahi-Zanjani, B. Toxic hepatitis in a group of 20 male body-builders taking dietary supplements. Food Chem. Toxicol. 2012, 50, 3826–3832. [CrossRef][PubMed]
24. Kafrouni, M.I.; Anders, R.A.; Verma, S. Hepatotoxicity associated with dietary supplements containing anabolic steroids. Clin. Gastroenterol. Hepatol. 2007, 5, 809–812. [CrossRef][PubMed]
25. Shah, N.L.; Zacharias, I.; Khettry, U.; Afdhal, N.; Gordon, F.D. Methasteron-associated cholestatic liver injury: Clinicopathologic findings in 5 cases. Clin. Gastroenterol. Hepatol. 2008, 6, 255–258. [CrossRef][PubMed]
26. Krishnan, P.V.; Feng, Z.Z.; Gordon, S.C. Prolonged intrahepatic cholestasis and renal failure secondary to anabolic androgenic steroid-enriched dietary supplements. J. Clin. Gastroenterol. 2009, 43, 672–675. [CrossRef][PubMed]
27. Schwingel, P.A.; Cotrim, H.P.; Dos Santos, C.R., Jr.; Dos Santos, A.O.; de Andrade, A.R.; Carruego, M.V.; Zoppi, C.C. Recreational Anabolic-Androgenic Steroid Use Associated With Liver Injuries among Brazilian Young Men. Subst. Use Misuse 2015, 50, 1490–1498. [CrossRef][PubMed]
28. Turani, H.; Levi, J.; Zevin, D.; Kessler, E. Hepatic lesions in patients on anabolic androgenic therapy. Isr. J. Med. Sci. 1983, 19, 332–337. [PubMed]
29. Choi, S.K.; Jin, J.S.; Cho, S.G.; Choi, S.J.; Kim, C.S.; Choe, Y.M.; Lee, K.Y. Spontaneous liver rupture in a patient with peliosis hepatis: A case report. World J. Gastroenterol. 2009, 15, 5493–5497. [CrossRef][PubMed]
30. Karasawa, T.; Shikata, T.; Smith, R.D. Peliosis hepatis. Report of nine cases. Acta Pathol. Jpn. 1979, 29, 457–469. [PubMed]
31. Patil, J.J.; O'Donohoe, B.; Loyden, C.F.; Shanahan, D. Near-fatal spontaneous hepatic rupture associated with anabolic androgenic steroid use: A case report. Br. J. Sports Med. 2007, 41, 462–463. [CrossRef][PubMed]
32. Agbenyefia, P.; Arnold, C.A.; Kirkpatrick, R. Cholestatic JaundiceWith the Use of Methylstenbolone and Dymethazine, Designer Steroids Found in Super DMZ Rx 2.0 “Nutritional Supplement” A Case Report III. J. Investig. Med. High Impact Case Rep. 2014, 2. [PubMed]
33. Hymel, B.M.; Victor, D.W.; Alvarez, L.; Shores, N.J.; Balart, L.A. Mastabol induced acute cholestasis: A case report. World J. Hepatol. 2013, 5, 133–136. [CrossRef][PubMed]
34. Ishak, K.G.; Zimmerman, H.J. Hepatotoxic effects of the anabolic/androgenic steroids. Semin. Liver Dis. 1987, 7, 230–236. [CrossRef][PubMed]
35. Brazeau, M.J.; Castaneda, J.L.; Huitron, S.S.; Wang, J. A Case Report of Supplement-Induced Hepatitis in an Active Duty Service Member. Mil. Med. 2015, 180, e844–e846. [CrossRef][PubMed]
36. Sánchez-Osorio, M.; Duarte-Rojo, A.; Martínez-Benítez, B.; Torre, A.; Uribe, M. Anabolic-androgenic steroids and liver injury. Liver Int. 2008, 28, 278–282. [CrossRef][PubMed]
37. Vilella, A.L.; Limsuwat, C.; Williams, D.R.; Seifert, C.F. Cholestatic Jaundice as a Result of Combination Designer Supplement Ingestion. Ann. Pharmacother. 2013, 47, e33. [CrossRef][PubMed]
38. El Sherrif, Y.; Potts, J.R.; Howard, M.R.; Barnardo, A.; Cairns, S.; Knisely, A.S.; Verma, S. Hepatotoxicity from anabolic androgenic steroidsmarketed as dietary supplements: Contribution fromATP8B1/ABCB11mutations? Liver Int. 2013, 33, 1266–1270. [CrossRef][PubMed]
39. Schwingel, P.A.; Cotrim, H.P.; Salles, B.R.; Almeida, C.E.; dos Santos, C.R., Jr.; Nachef, B.; Andrade, A.R.; Zoppi, C.C. Anabolic-androgenic steroids: A possible new risk factor of toxicant-associated fatty liver disease. Liver Int. 2011, 31, 348–353. [CrossRef][PubMed]
40. Kanayama, G.; Hudson, J.I.; Pope, H.G. Jr. Long-termpsychiatric andmedical consequences of anabolic-androgenic steroid abuse: A looming public health concern? Drug Alcohol Depend. 2008, 98, 1–12. [CrossRef][PubMed]
41. Gavilan, J.C.; Bermudez, F.J.; Salgado, F.; Pena, D. Phytotherapy and hepatitis. Rev. Clin. Esp. 1999, 199, 693–694. [PubMed]
42. Pillukat, M.H.; Bester, C.; Hensel, A.; Lechtenberg, M.; Petereit, F.; Beckebaum, S.; Müller, K.M.; Schmidt, H.H. Concentrated green tea extract induces severe acute hepatitis in a 63-year-old woman—A case report with pharmaceutical analysis. J. Ethnopharmacol. 2014, 155, 165–170. [CrossRef][PubMed]
43. Molinari, M.; Watt, K.D.; Kruszyna, T.; Nelson, R.; Walsh, M.; Huang, W.Y.; Nashan, B.; Peltekian, K. Acute liver failure induced by green tea extracts: Case report and review of the literature. Liver Transpl. 2006, 12, 1892–1895. [CrossRef][PubMed]
44. Verhelst, X.; Burvenich, P.; Van Sassenbroeck, D.; Gabriel, C.; Lootens, M.; Baert, D. Acute hepatitis after treatment for hair loss with oral green tea extracts (Camellia sinensis). Acta Gastroenterol. Belg. 2009, 72, 262–264. [PubMed]
45. Patel, S.S.; Beer, S.; Kearney, D.L.; Phillips, G.; Carter, B.A. Green tea extract: A potential cause of acute liver failure. World J. Gastroenterol. 2013, 19, 5174–5177. [CrossRef][PubMed]
46. Lorenzo-Almorós, A.; Polo-Sabau, J.; Barrio-Dorado, M.P.; Ruggiero, G.M. Acute liver injury induced by green tea extracts. Gastroenterol. Hepatol. 2015, 38, 44–45. [CrossRef][PubMed]
47. Bjornsson, E.; Olsson, R. Serious adverse liver reactions associated with herbal weight-loss supplements. J. Hepatol. 2007, 47, 295–297. [CrossRef][PubMed]
48. Abu el Wafa, Y.; Benavente Fernández, A.; Talavera Fabuel, A.; Pérez Ramos, M.A.; Ramos-Clemente, J.I. Acute hepatitis induced by Camellia sinensis (green tea). An. Med. Interna 2005, 22, 298. [PubMed]
49. García-Morán, S.; Sáez-Royuela, F.; Gento, E.; López Morante, A.; Arias, L. Acute hepatitis associated with Camellia thea and Orthosiphon stamineus ingestión. Gastroenterol. Hepatol. 2004, 27, 559–560. [CrossRef]
50. Dueñas Sadornil, C.; Fabregas Puigtió, S.; Durández, R. Hepatotoxicity due to Camelia sinensis. Med. Clin. 2004, 122, 677–678. [CrossRef]
51. Thiolet, C.; Mennecier, D.; Bredin, C.; Moulin, O.; Rimlinger, H.; Nizou, C.; Vergeau, B.; Farret, O. Acute cytolysis induced by Chinese tea. Gastroenterol. Clin. Biol. 2002, 26, 939–940. [PubMed]
52. Weinstein, D.H.; Twaddell, W.S.; Raufman, J.P.; Philosophe, B.; Mindikoglu, A.L. SlimQuick™-associated hepatotoxicity in a woman with -1 antitrypsin heterozygosity. World J. Hepatol. 2012, 4, 154–157. [CrossRef][PubMed]
53. Sarma, D.N.; Barrett, M.L.; Chavez, M.L.; Gardiner, P.; Ko, R.; Mahady, G.B.; Marles, R.J.; Pellicore, L.S.; Giancaspro, G.I.; Low Dog, T. Safety of green tea extracts. A systematic review by the US pharmacopeia. Drug Saf. 2008, 31, 469–484. [CrossRef][PubMed]
54. Mazzanti, G.; Menniti-Ippolito, F.; Moro, P.A.; Cassetti, F.; Raschetti, R.; Santuccio, C.; Mastrangelo, S. Hepatotoxicity from green tea: A review of the literature and two unpublished cases. Eur. J. Clin. Pharmacol. 2009, 65, 331–341. [CrossRef][PubMed]
55. Galati, G.; Lin, A.; Sultan, A.M.; O’Brien, P.J. Cellular and in vivo hepatotoxicity caused by green tea phenolic acids and catechins. Free Radic. Biol. Med. 2006, 40, 570–580. [CrossRef][PubMed]
56. Lin, B.R.; Yu, C.J.; Chen, W.C.; Lee, H.S.; Chang, H.M.; Lee, Y.C.; Chien, C.T.; Chen, C.F. Green tea extract supplement reduces D galactosamine-induced acute liver injury by inhibition of apoptotic and proinflammatory signaling. J. Biomed. Sci. 2009, 16, 35. [CrossRef][PubMed]
57. Kobayashi, H.; Tanaka, Y.; Asagiri, K.; Asakawa, T.; Tanikawa, K.; Kage, M.; Yagi, M. The antioxidant effect of green tea catechin ameliorates experimental liver injury. Phytomedicine 2010, 17, 197–202. [CrossRef][PubMed]
58. Zhong, Z.; Froh, M.; Lehnertm, M.; Schoonhoven, R.; Yang, L.; Lind, H.; Lemasters, J.J.; Thurman, R.G. Polyphenols from Camellia sinenesis attenuate experimental cholestasis- induced liver fibrosis in rats. Am. J. Physiol. Gastrointest. Liver Physiol. 2003, 285, G1004–G1013. [CrossRef][PubMed]
59. Jin, X.; Zheng, R.H.; Li, Y.M. Green tea consumption and liver disease, a systematic review. Liver Int. 2008, 28, 990–996. [CrossRef][PubMed]
60. Gloro, R.; Hourmand-Ollivier, I.; Mosquet, B.; Mosquet, L.; Rousselot, P.; Salamé, E.; Piquet, M.A.; Dao, T. Fulminant hepatitis during self-medication with hydroalcoholic extract of green tea. Eur. J. Gastroenterol. Hepatol. 2005, 17, 1135–1137. [CrossRef][PubMed]
61. Pedrós, C.; Cereza, G.; García, N.; Laporte, J.R. Liver toxicity of Camellia sinensis dried etanolic extract. Med. Clin. 2003, 121, 598–599. [CrossRef]
62. Yellapu, R.K.; Mittal, V.; Grewal, P.; Fiel, M.; Schiano, T. Acute liver failure caused by “fat burners” and dietary supplements: A case report and literature review. Can. J. Gastroenterol. 2011, 25, 157–160. [PubMed]
63. Teschke, R.; Genthner, A.; Wolff, A.; Frenzel, C.; Schulze, J.; Eickhoff, A. Herbal hepatotoxicity: Analysis of cases with initially reported positive re-exposure tests. Dig. Liver Dis. 2014, 46, 264–269. [CrossRef][PubMed]
64. Ramos, R.; Mascarenhas, J.; Duarte, P.; Vicente, C.; Casteleiro, C. Conjugated linoleic acid-induced toxic hepatitis: First case report. Dig. Dis. Sci. 2009, 54, 1141–1143. [CrossRef][PubMed]
65. Nortadas, R.; Barata, J. Fulminant hepatitis during self-medication with conjugated linoleic acid. Ann Hepatol. 2012, 11, 265–267. [PubMed]
66. Bilal, M.; Patel, Y.; Burkitt, M.; Babich, M. Linoleic Acid Induced Acute Hepatitis: A Case Report and Review of the Literature. Case Rep. Hepatol. 2015. [CrossRef][PubMed]
67. Ingólfsdóttir, K. Usnic acid. Phytochemistry 2002, 61, 729–736. [CrossRef]
68. Moreira, C.T.; Oliveira, A.L.; Comar, J.F.; Peralta, R.M.; Bracht, A. Harmful effects of usnic acid on hepatic metabolism. Chem. Biol. Interact. 2013, 203, 502–511. [CrossRef][PubMed]
69. Han, D.; Matsumaru, K.; Rettori, D.; Kaplowitz, N. Usnic acid-induced necrosis of cultured mouse hepatocytes: Inhibition of mitochondrial function and oxidative stress. Biochem. Pharmacol. 2004, 67, 439–451. [CrossRef][PubMed]
70. Favreau, J.T.; Ryu, M.L.; Braunstein, G.; Orshansky, G.; Park, S.S.; Coody, G.L.; Love, L.A.; Fong, T.L. Severe hepatotoxicity associated with the dietary supplement LipoKinetix. Ann. Intern. Med. 2002, 136, 590–595. [CrossRef][PubMed]
71. Durazo, F.A.; Lassman, C.; Han, S.H.; Saab, S.; Lee, N.P.; Kawano, M.; Saggi, B.; Gordon, S.; Farmer, D.G.; Yersiz, H., et al. Fulminant liver failure due to usnic acid for weight loss. Am. J. Gastroenterol. 2004, 99, 950–952. [CrossRef][PubMed]
72. Sanchez, W.; Maple, J.T.; Burgart, L.J.; Kamath, P.S. Severe hepatotoxicity associated with use of a dietary supplement containing usnic acid. Mayo Clin. Proc. 2006, 81, 541–544. [CrossRef][PubMed]
73. Estes, J.D.; Stolpman, D.; Olyaei, A.; Corless, C.L.; Ham, J.M.; Schwartz, J.M.; Orloff, S.L. High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure. Arch. Surg. 2003, 138, 852–858. [CrossRef][PubMed]
74. Neff, G.W.; Reddy, K.R.; Durazo, F.A.; Meyer, D.; Marrero, R.; Kaplowitz, N. Severe hepatotoxicity associated with the use of weight loss diet supplements containing ma huang or usnic acid. J. Hepatol. 2004, 41, 1062–1064. [CrossRef][PubMed]
75. Hsu, L.M.; Huang, Y.S.; Chang, F.Y.; Lee, S.D. “Fat burner” herb, usnic acid, induced acute hepatitis in a family. J. Gastroenterol. Hepatol. 2005, 20, 1138–1139. [CrossRef][PubMed]
76. Herbalife. Available online: http://ir.herbalife.com/releasedetail.cfm?ReleaseID=891717 (accesed on 9 January 2016).
77. Herbalife. Available online: http://ir.herbalife.com/releasedetail.cfm?ReleaseID=898740 (accesed on 9 January 2016).
78. Schoepfer, A.M.; Engel, A.; Fattinger, K.; Marbet, U.A.; Criblez, D.; Reichen, J.; Zimmermann, A.; Oneta, C.M. Herbal does not mean innocuous: Ten cases of severe hepatotoxicity associated with dietary supplements from Herbalife products. J. Hepatol. 2007, 47, 521–526. [CrossRef][PubMed]
79. Stickel, F.; Droz, S.; Patsenker, E.; Bögli-Stuber, K.; Aebi, B.; Leib, S.L. Severe hepatotoxicity following ingestion of Herbalife nutritional supplements contaminated with Bacillus subtilis. J. Hepatol. 2009, 50, 111–117. [CrossRef][PubMed]
80. Elinav, E.; Pinsker, G.; Safadi, R.; Pappo, O.; Bromberg, M.; Anis, E.; Keinan-Boker, L.; Broide, E.; Ackerman, Z.; Kaluski, D.N., et al. Association between consumption of Herbalife nutritional supplements and acute hepatotoxicity. J. Hepatol. 2007, 47, 514–520. [CrossRef][PubMed]
81. Duque, J.M.; Ferreiro, J.; Salgueiro, E.; Manso, G. Hepatotoxicity associated with the consumption of herbal slimming products. Med. Clin. 2007, 128, 238–239.
82. Manso, G.; López-Rivas, L.; Duque, J.M.; Salgueiro, E. Spanish reports of hepatotoxicity associated with Herbalife products. J. Hepatol. 2008, 49, 289–290. [CrossRef][PubMed]
83. Manso, G.; López-Rivas, L.; Salgueiro, M.E.; Duque, J.M.; Jimeno, F.J.; Andrade, R.J.; Lucena, M.I. Continuous reporting of new cases in Spain supports the relationship between Herbalife® products and liver injury. Pharmacoepidemiol. Drug Saf. 2011, 20, 1080–1087. [CrossRef][PubMed]
84. Chao, S.; Anders, M.; Turbay, M.; Olaiz, E.; Mc Cormack, L.; Mastai, R. Toxic hepatitis by consumption Herbalife products a case report. Acta Gastroenterol. Latinoam. 2008, 38, 274–277. [PubMed]
85. Jóhannsson, M.; Ormarsdóttir, S.; Olafsson, S. Hepatotoxicity associated with the use of Herbalife. Laeknabladid 2010, 96, 167–172. [PubMed]
86. Chen, G.C.; Ramanathan, V.S.; Law, D.; Funchain, P.; Chen, G.C.; French, S.; Shlopov, B.; Eysselein, V.; Chung, D.; Reicher, S., et al. Acute liver injury induced by weight-loss herbal supplements. World J. Hepatol. 2010, 2, 410–415. [CrossRef][PubMed]
87. Mengual-Moreno, E.; Lizarzábal-García, M.; Ruiz-Soler, M.; Silva-Suarez, N.; Andrade-Bellido, R.; Lucena-González, M.; Bessone, F.; Hernández, N.; Sánchez, A.; Medina-Cáliz, I. Case reports of drug-induced liver injury in a reference hospital of Zulia state, Venezuela. Investig. Clin. 2015, 56, 3–12.
88. Stevens, T.; Qadri, A.; Zein, N.N. Two patients with acute liver injury associated with use of the herbal weight-loss supplement hydroxycut. Ann. Intern. Med. 2005, 142, 477–478. [CrossRef][PubMed]
89. Jones, F.J.; Andrews, A.H. Acute liver injury associated with the herbal supplement hydroxycut in a soldier deployed to Iraq. Am. J. Gastroenterol. 2007, 102, 2357–2358. [CrossRef][PubMed]
90. Dara, L.; Hewett, J.; Lim, J.K. Hydroxycut hepatotoxicity: A case series and review of liver toxicity from herbal weight loss supplements. World J. Gastroenterol. 2008, 14, 6999–7004. [CrossRef][PubMed]
91. Shim, M.; Saab, S. Severe hepatotoxicity due to Hydroxycut: A case report. Dig. Dis. Sci. 2009, 54, 406–408. [CrossRef][PubMed]
92. Fong, T.L.; Klontz, K.C.; Canas-Coto, A.; Casper, S.J.; Durazo, F.A.; Davern, T.J.; Hayashi, P.; Lee, W.M.; Seeff, L.B. Hepatotoxicity due toHydroxycut: A case series. Am. J. Gastroenterol. 2010, 105, 1561–1566. [CrossRef][PubMed]
93. Sharma, T.; Wong, L.; Tsai, N.; Wong, R.D. Hydroxycut® (herbal weight loss supplement) Induced Hepatotoxicity: A Case Report and Review of Literature. Hawaii Med. J. 2010, 69, 188–190. [PubMed]
94. Kaswala, D.H.; Shah, S.; Patel, N.; Raisoni, S.; Swaminathan, S. Hydroxycut-induced Liver Toxicity. Ann. Med. Health Sci. Res. 2014, 4, 143–145. [CrossRef][PubMed]
95. FDA. Available online: http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm152152.htm (accessed on 4 April 2016).
96. Edwards, J. How Hydroxycut Stays in Business Despite Deaths, Recalls and a Class-Action Suit. CBS New. Available online: http://www.cbsnews.com/news/how-hydroxycut-stays-in-business-despite-deaths-recallsand- a-class-action-suit/ (accessed on 9 January 2016).
97. Araujo, J.L.; Worman, H.J. Acute liver injury associated with a newer formulation of the herbal weight loss supplement Hydroxycut. BMJ Case Rep. 2015. [CrossRef][PubMed]
98. Laczek, J.; Duncan, M. Three cases of acute hepatitis in patients taking hydroxycut bodybuilding supplement. Am. J. Gastroenterol. 2008, 103, S143–S144.
99. Haimowitz, S.; Hsieh, J.; Shcherba, M.; Averbukh, Y. Liver failure after Hydroxycut™ use in a patient with undiagnosed hereditary coproporphyria. J. Gen. Intern. Med. 2015, 30, 856–859. [PubMed]
100. Smith, T.B.; Staub, B.A.; Natarajan, G.M.; Lasorda, D.M.; Poornima, I.G. Acute myocardial infarction associated with dietary supplements containing 1,3-dimethylamylamine and Citrus aurantium. Tex. Heart Inst. J. 2014, 41, 70–72. [CrossRef][PubMed]
101. Foley, S.; Butlin, E.; Shields, W.; Lacey, B. Experience with OxyELITE pro and acute liver injury in active duty service members. Dig. Dis. Sci. 2014, 59, 3117–3121. [CrossRef][PubMed]
102. Roytman, M.M.; Pörzgen, P.; Lee, C.L.; Huddleston, L.; Kuo, T.T.; Bryant-Greenwood, P.; Wong, L.L.; Tsai, N. Outbreak of severe hepatitis linked to weight-loss supplement OxyELITE Pro. Am. J. Gastroenterol. 2014, 109, 1296–1298. [CrossRef][PubMed]
103. Johnston, D.I.; Chang, A.; Viray, M.; Chatham-Stephens, K.; He, H.; Taylor, E.; Wong, L.L.; Schier, J.; Martin, C.; Fabricant, D., et al. Hepatotoxicity associated with the dietary supplement OxyELITE Pro™—Hawaii, 2013. Drug Test. Anal. 2015. [CrossRef][PubMed]
104. Teschke, R.; Schwarzenboeck, A.; Frenzel, C.; Schulze, J.; Eickhoff, A.; Wolff, A. The mystery of the Hawaii liver disease cluster in summer 2013: A pragmatic and clinical approach to solve the problem. Ann. Hepatol. 2016, 15, 91–109. [CrossRef][PubMed]
105. Klontz, K.C.; DeBeck, H.J.; LeBlanc, P.; Mogen, K.M.; Wolpert, B.J.; Sabo, J.L.; Salter, M.; Seelman, S.L.; Lance, S.E.; Monahan, C., et al. The Role of Adverse Event Reporting in the FDA Response to a Multistate Outbreak of Liver Disease Associated with a Dietary Supplement. Public Health Rep. 2015, 130, 526–532. [PubMed]
106. Olson, J.A. Vitamin A. In Present Knowledge in Nutrition, 7th ed.; Ziegler, E.E., Filer, L.J., Jr., Eds.; International Life Sciences Institute: Washington, DC, USA, 2001; pp. 109–119.
107. Hathcock, J.N.; Hattan, D.G.; Jenkins, M.Y.; McDonald, J.T.; Sundaresan, P.R.; Wilkening, V.L. Evaluation of vitamin A toxicity. Am. J. Clin. Nutr. 1990, 52, 183–202. [PubMed]
108. Penniston, K.L.; Tanumihardjo, S.A. The acute and chronic effects of vitamin A. Am. J. Clin. Nutr. 2006, 83, 191–201. [PubMed]
109. Carpenter, T.O.; Pettifor, J.M.; Russell, R.M.; Pitha, J.; Mobarhan, S.; Ossip, M.S.; Wainer, S.; Anast, C.S. Severe hypervitaminosis A in siblings: Evidence of variable tolerance to retinol intake. J. Pediatr. 1987, 111, 507–512. [CrossRef]
110. Geubel, A.P.; De Galocsy, C.; Alves, N.; Rahier, J.; Dive, C. Liver damage caused by therapeutic vitamin A administration: Estimate of dose-related toxicity in 41 cases. Gastroenterology 1991, 100, 1701–1709. [PubMed]
111. Ramanathan, V.S.; Hensley, G.; French, S.; Eysselein, V.; Chung, D.; Reicher, S.; Pham, B. Hypervitaminosis A inducing intra-hepatic cholestasis—A rare case report. Exp. Mol. Pathol. 2010, 88, 324–325. [CrossRef][PubMed]
112. Becker, P.; Maurer, B.; Schirmacher, P.; Waldherr, R.; Parlesak, A.; Bode, C.; Seitz, H.K. Vitamin A induced cholestatic hepatitis: A case report. Z Gastroenterol. 2007, 45, 1063–1066. [CrossRef][PubMed]
113. Croquet, V.; Pilette, C.; Lespine, A.; Vuillemin, E.; Rousselet, M.C.; Oberti, F.; Saint André, J.P.; Periquet, B.; François, S.; Ifrah, N., et al. Hepatic hyper-vitaminosis A: Importance of retinyl ester level determination. Eur. J. Gastroenterol. Hepatol. 2000, 12, 361–364. [CrossRef][PubMed]
114. Kowalski, T.E.; Falestiny, M.; Furth, E.; Malet, P.F. Vitamin A hepatotoxicity: A cautionary note regarding 25,000 IU supplements. Am. J. Med. 1994, 97, 523–528. [CrossRef]
115. Leo, M.A.; Lieber, C.S.A. Vitamin A, and β-carotine: Adverse interactions, including hepatotoxicity and carcinogenicity. Am. J. Clin. Nutr. 1999, 69, 1071–1085. [PubMed]
116. Nollevaux, M.C.; Guiot, Y.; Horsmans, Y.; Leclercq, I.; Rahier, J.; Geubel, A.P.; Sempoux, C. Hypervitaminosis A-induced liver fibrosis: Stellate cell activation and daily dose consumption. Liver Int. 2006, 26, 182–186. [CrossRef][PubMed]
117. Muenter, M.D.; Perry, H.O.; Ludwig, J. Chronic vitamin A intoxication in adults. Hepatic, neurologic and dermatologic complications. Am. J. Med. 1971, 50, 129–136. [CrossRef]
118. Russell, R.M.; Boyer, J.L.; Bagheri, S.A.; Hruban, Z. Hepatic injury from chronic hypervitaminosis a resulting in portal hypertension and ascites. N. Engl. J. Med. 1974, 291, 435–440. [CrossRef][PubMed]
119. Jacques, E.A.; Buschmann, R.J.; Layden, T.J. The histopathologic progression of vitamin A-induced hepatic injury. Gastroenterology 1979, 76, 599–602. [PubMed]
120. Herbert, V.Will questionable nutrition overwhelm nutrition science? Am. J. Clin. Nutr. 1981, 34, 2848–2853. [PubMed]
121. Farris, W.A.; Erdman, J.W. Protracted hypervitaminosis A following long-term, low-level intake. J. Am. Med. Assoc. 1982, 247, 1317. [CrossRef]
122. Weber, F.L.; Mitchell, G.E.; Powell, D.E.; Reiser, B.J.; Banwell, J.G. Reversible hepatotoxicity associated with hepatic vitamin A accumulation in a protein-deficient patient. Gastroenterology 1982, 82, 118–123. [PubMed]
123. Hatoff, D.E.; Gertler, S.L.; Miyai, K.; Parker, B.A.; Weiss, J.B. Hypervitaminosis A unmasked by acute viral hepatitis. Gastroenterology 1982, 82, 124–128. [PubMed]
124. Park, H.M.; Ransburg, R.; Roth, C.; Meadows, J. Scintigraphic dissociation of reticuloendothelial and hepatocyte function in chronic vitamin A hepatotoxicity. Clin. Nucl. Med. 1985, 10, 364–366. [CrossRef][PubMed]
125. Inkeles, S.B.; Connor, W.E.; Illingworth, D.R. Hepatic and dermatologic manifestations of chronic hypervitaminosis A in adults. Report of two cases. Am. J. Med. 1986, 80, 491–496. [CrossRef]
126. Vincent, L.M. Scintigraphic dissociation of reticuloendothelial and hepatocyte function in chronic vitamin A hepatotoxicity. Clin. Nucl. Med. 1986, 11, 67. [CrossRef][PubMed]
127. Witzleben, C.L. Case 5. Vitamin A hepatotoxicity. Pediatr. Pathol. 1986, 6, 481–484. [CrossRef][PubMed]
128. Minuk, G.Y.; Kelly, J.K.; Hwang, W.S. Vitamin A hepatotoxicity in multiple family members. Hepatology 1988, 8, 272–275. [CrossRef][PubMed]
129. Jorens, P.G.; Michielsen, P.P.; Pelckmans, P.A.; Fevery, J.; Desmet, V.J.; Geubel, A.P.; Rahier, J.; van Maercke, Y.M. Vitamin A abuse: Development of cirrhosis despite cessation of vitamin A. A six-year clinical and histopathologic follow-up. Liver 1992, 12, 381–386. [CrossRef][PubMed]
130. Cheruvattath, R.; Orrego, M.; Gautam, M.; Byrne, T.; Alam, S.; Voltchenok, M.; Edwin, M.; Wilkens, J.; Williams, J.W.; Vargas, H.E. Vitamin A toxicity: When one a day doesn't keep the doctor away. Liver Transpl. 2006, 12, 1888–1891. [CrossRef][PubMed]
131. Krasinski, S.D.; Russell, R.M.; Otradovec, C.L.; Sadowski, J.A.; Hartz, S.C.; Jacob, R.A.; McGandy, R.B. Relationship of vitamin A and vitamin E intake to fasting plasma retinol, retinol-binding protein, retinyl esters, carotene, alpha-tocopherol, and cholesterol among elderly people and young adults: Increased plasma retinyl esters among vitamin A-supplement users. Am. J. Clin. Nutr. 1989, 49, 112–120. [PubMed]
132. Fontanarosa, P.B.; Rennie, D.; DeAngelis, C.D. The need for regulation of dietary supplements—Lessons from ephedra. J. Am. Med. Assoc. 2003, 289, 1568–1570. [CrossRef][PubMed]
133. Corey, R.; Werner, K.T.; Singer, A.; Moss, A.; Smith, M.; Noelting, J.; Rakela, J. Acute liver failure associated with Garcinia cambogia use. Ann. Hepatol. 2015, 15, 123–126. [CrossRef]
134. Melendez-Rosado, J.; Snipelisky, D.; Matcha, G.; Stancampiano, F. Acute hepatitis induced by pure Garcinia cambogia. J. Clin. Gastroenterol. 2015, 49, 449–450. [CrossRef][PubMed]
135. Teschke, R.; Frenzel, C.; Schulze, J.; Eickhoff, A. Herbal hepatotoxicity: Challenges and pitfalls of causality assessment methods. World J. Gastroenterol. 2013, 19, 2864–2882. [CrossRef][PubMed]
136. Navarro, V.J.; Lucena, M.I. Hepatotoxicity Induced by Herbal and Dietary Supplements. Semin. Liver Dis. 2014, 34, 172–193. [PubMed]
137. Seddik, M.; Lucidarme, D.; Creusy, C.; Filoche, B. Is Exolise hepatotoxic? Gastroenterol. Clin. Biol. 2001, 25, 834–835. [PubMed]
138. Vial, T.; Bernard, G.; Lewden, B.; Dumortier, J.; Descotes, J. Acute hepatitis due to Exolise, a Camellia sinensis-derived drug. Gastroenterol. Clin. Biol. 2003, 27, 1166–1167. [PubMed]
139. Peyrin-Biroulet, L.; Petitpain, N.; Kalt, P.; Ancel, D.; Petit-Laurent, F.; Trechot, P.; Barraud, H.; Bronowicki, J.P. Probable hepatoxicity from epigallocatecol gallate used for phytotherapy. Gastroenterol. Clin. Biol. 2004, 28, 404–406. [CrossRef]
140. Mathieu, N.; Bouallegue, L.; Mognol, P.; Vallot, T.; Soulé, J.C. Hepatic toxicity probably due to X-elles used in phytotherapy. Gastroenterol. Clin. Biol. 2005, 29, 1188–1189. [CrossRef]
141. Bonkovsky, H.L. Hepatotoxicity associated with supplements containing Chinese green tea (Camellia sinensis). Ann. Intern. Med. 2006, 144, 68–71. [CrossRef][PubMed]
142. Javaid, A.; Bonkovsky, H.L. Hepatotoxicity due to extracts of Chinese green tea (Camellia sinensis): Agrowing concern. J. Hepatol. 2006, 45, 334–335. [CrossRef][PubMed]
143. Jimenez-Saenz, M.; Martinez-Sanchez, M. Acute hepatitis associated with the use of green tea infusions. J. Hepatol. 2006, 44, 616–617. [CrossRef][PubMed]
144. Rohde, J.; Jacobsen, C.; Kromann-Andersen, H. Toxic hepatitis triggered by green tea. Ugeskr. Laeger 2011, 173, 205–106. [PubMed]
145. Martínez-Sierra, C.; Rendón Unceta, P.; Martín Herrera, L. Acute hepatitis after green tea ingestion. Med. Clin. 2006, 127, 119. [CrossRef]
146. Federico, A.; Tiso, A.; Loguercio, C. A case of hepatotoxicity caused by green tea. Free Radic. Biol. Med. 2007, 43, 474. [CrossRef][PubMed]
147. Prieto de Paula, J.M.; Gómez Barquero, J.; Franco Hidalgo, S. Toxic hepatitis due to Camellia sinensis. Gastroenterol. Hepatol. 2008, 31, 402. [CrossRef][PubMed]
148. Bergman, J.; Schjøtt, J. Hepatitis caused by Lotus-f3? Basic Clin. Pharmacol. Toxicol. 2009, 104, 414–416. [CrossRef][PubMed]
149. McDonnell, W.M.; Bhattacharya, R.; Halldorson, J.B. Fulminant hepatic failure after use of the herbal weight-loss supplement exilis. Ann. Intern. Med. 2009, 151, 673–674. [CrossRef][PubMed]
150. Amariles, P.; Angulo, N.; Agudelo-Agudelo, J.; Gaviria, G. Hepatitis associated with aqueous green tea infusions: A case study. Farm. Hosp. 2009, 33, 289–291. [CrossRef]
151. Jiménez-Encarnación, E.; Ríos, G.; Muñoz-Mirabal, A.; Vilá, L.M. Euforia-induced acute hepatitis in a patient with scleroderma. BMJ Case Rep. 2012. [CrossRef][PubMed]
152. Gallo, E.; Maggini, V.; Berardi, M.; Pugi, A.; Notaro, R.; Talini, G.; Vannozzi, G.; Bagnoli, S.; Forte, P.; Mugelli, A., et al. Is green tea a potential trigger for autoimmune hepatitis? Phytomedicine 2013, 20, 1186–1189. [CrossRef][PubMed]
153. Whitsett, M.; Marzio, D.H.; Rossi, S. SlimQuick™—Associated Hepatotoxicity Resulting in Fulminant Liver Failure and Orthotopic Liver Transplantation. ACG Case Rep. J. 2014, 1, 220–222. [PubMed]
154. Arzenton, E.; Magro, L.; Paon, V.; Capra, F.; Apostoli, P.; Guzzo, F.; Conforti, A.; Leone, R. Acute hepatitis caused by green tea infusion: A case report. Adv. Pharmacoepidemiol. Drug Saf. 2014. [CrossRef]
155. Fernández, J.; Navascués, C.; Albines, G.; Franco, L.; Pipa, M.; Rodríguez, M. Three cases of liver toxicity with a dietary supplement intended to stop hair loss. Rev. Esp. Enferm. Dig. 2014, 106, 552–555. [PubMed]
156. Cruz, A.C.D.; Patel, T.; Maynard, E.; Shah, M.; Lee, E.Y.; Angulo, P. Mo1814 Fulminant Liver Failure Secondary to “Saba Appetite Control and Energy” Weight Loss Supplement. Gastroenterology 2014, 146, 1002. [CrossRef]
157. Vanstraelen, S.; Rahier, J.; Geubel, A.P. Jaundice as a misadventure of a green tea (Camellia sinensis) lover: A case report. Acta Gastroenterol. Belg. 2008, 71, 409–412. [PubMed]
158. Wingert, N.; Tavakoli, H.; Yoder, E. Acute hepatitis and personality change in a 31-year-old man taking prohormone supplement SUS500. Psychosomatics 2010, 51, 340–344. [CrossRef]
159. Luciano, R.L.; Castano, E.; Moeckel, G.; Perazella, M.A. Bile acid nephropathy in a bodybuilder abusing an anabolic androgenic steroid. Am. J. Kidney Dis. 2014, 64, 473–476. [CrossRef][PubMed]